Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients

Journal of Infection

Volumn 73, Issue 5, 2016, Pages 468-475

  Ko, Jae Hoon ^a   Park, Ga Eun ^a   Lee, Ji Yeon ^a   Lee, Ji Yong ^a   Cho, Sun Young ^a   Ha, Young Eun ^a   Kang, Cheol In ^a   Kang, Ji Man ^a   Kim, Yae Jean ^a   Huh, Hee Jae ^a   Ki, Chang Seok ^a   Jeong, Byeong Ho ^a   Park, Jinkyeong ^a   Chung, Chi Ryang ^a   Chung, Doo Ryeon ^a   Song, Jae Hoon ^a   Peck, Kyong Ran ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Disease progression; Middle East respiratory syndrome coronavirus; Pneumonia; Predictive factor; Respiratory failure

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONAVIRUS INFECTION; DISEASE COURSE; EPIDEMIC; FEMALE; FEVER; HUMAN; HYPERTENSION; INFECTION CONTROL; LYMPHOCYTOPENIA; MALE; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TERTIARY CARE CENTER; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; VIRUS PNEUMONIA; AGED; COMORBIDITY; DISEASE EXACERBATION; ELECTRONIC HEALTH RECORD; MIDDLE AGED; PATHOPHYSIOLOGY; PNEUMONIA; SOUTH KOREA; UNIVERSITY HOSPITAL;

ADULT; AGED; COMORBIDITY; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; DISEASE PROGRESSION; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; REPUBLIC OF KOREA; RESPIRATORY INSUFFICIENCY; RISK FACTORS;

EID: 84994528223     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2016.08.005     Document Type: Article

References (35)

1. 1 Zumla, A., Hui, D.S., Perlman, S., Middle East respiratory syndrome. Lancet 386 (2015), 995–1007.
2. 2 Summary of current situation, Literature Update and Risk Assessment. 2015 July 7, World Health Organization http://www.who.int/csr/disease/coronavirus_infections/risk-assessment-7july2015/en.
3. 3 Middle east respiratory syndrome coronavirus (MERS-CoV) – Republic of Korea. 2015 July 10, World Health Organization http://www.who.int/csr/don/10-july-2015-mers-korea/en.
4. 4 An unexpected outbreak of Middle East respiratory syndrome coronavirus infection in the Republic of Korea, 2015. Infect Chemother 47 (2015), 120–122.
5. 5 Kim, Y., Lee, S., Chu, C., Choe, S., Hong, S., Shin, Y., The characteristics of middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea. Osong Public Health Res Perspect 7 (2016), 49–55.
6. 6 Cowling, B.J., Park, M., Fang, V.J., Wu, P., Leung, G.M., Wu, J.T., Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill, 20, 2015.
7. 7 Nishiura, H., Endo, A., Saitoh, M., Kinoshita, R., Ueno, R., Nakaoka, S., et al. Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis. BMJ Open, 6, 2016, e009936.
8. 8 Chowell, G., Abdirizak, F., Lee, S., Lee, J., Jung, E., Nishiura, H., et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med, 13, 2015, 210.
9. 9 Park, G.E., Ko, J.H., Peck, K.R., Lee, J.Y., Lee, J.Y., Cho, S.Y., et al. Control of an outbreak of Middle East respiratory syndrome in a tertiary hospital in Korea. Ann Intern Med 165 (2016), 87–93.
10. 10 Cho, S.Y., Kang, J.M., Ha, Y.E., Park, G.E., Lee, J.Y., Ko, J.H., et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet, 2016 Jul 8, 10.1016/S0140- 6736(16)30623-7 pii: S0140-6736(16)30623-7. [Epub ahead of print].
11. 11 Mizumoto, K., Endo, A., Chowell, G., Miyamatsu, Y., Saitoh, M., Nishiura, H., Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015. BMC Med, 13, 2015, 228.
12. 12 Corman, V.M., Albarrak, A.M., Omrani, A.S., Albarrak, M.M., Farah, M.E., Almasri, M., et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin Infect Dis 62 (2016), 477–483.
13. 13 Feikin, D.R., Alraddadi, B., Qutub, M., Shabouni, O., Curns, A., Oboho, I.K., et al. Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014. Emerg Infect Dis 21 (2015), 2029–2035.
14. 14 Majumder, M.S., Kluberg, S.A., Mekaru, S.R., Brownstein, J.S., Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015. Emerg Infect Dis 21 (2015), 2088–2090.
15. 15 Saad, M., Omrani, A.S., Baig, K., Bahloul, A., Elzein, F., Matin, M.A., et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 29 (2014), 301–306.
16. 16 Banik, G.R., Alqahtani, A.S., Booy, R., Rashid, H., Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia. Virol Sin 31 (2016), 81–84.
17. 17 Management of asymptomatic persons who are RTPCR positive for Middle East respiratory syndrome coronavirus (MERS-CoV), Interim Guidance, July 27, 2015, World Health Organization http://www.who.int/csr/disease/coronavirus_infections/management_of_asymptomatic_patients/en/ [Accessed 27.05.16].
18. 18 Madani, T.A., Case definition and management of patients with MERS coronavirus in Saudi Arabia. Lancet Infect Dis 14 (2014), 911–913.
19. 19 Oboho, I.K., Tomczyk, S.M., Al-Asmari, A.M., Banjar, A.A., Al-Mugti, H., Aloraini, M.S., et al. 2014 MERS-CoV outbreak in Jeddah – a link to health care facilities. N Engl J Med 372 (2015), 846–854.
20. 20 Woolf, B., On estimating the relation between blood group and disease. Ann Hum Genet 19 (1955), 251–253.
21. 21 Al Ghamdi, M., Alghamdi, K.M., Ghandoora, Y., Alzahrani, A., Salah, F., Alsulami, A., et al. Treatment outcomes for patients with Middle Eastern respiratory syndrome coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia. BMC Infect Dis, 16, 2016, 174.
22. 22 Modjarrad, K., Treatment strategies for Middle East respiratory syndrome coronavirus. J Virus Erad 2 (2016), 1–4.
23. 23 Chan, J.F., Yao, Y., Yeung, M.L., Deng, W., Bao, L., Jia, L., et al. Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J Infect Dis 212 (2015), 1904–1913.
24. 24 Interim infection prevention and control recommendations for hospitalized patients with Middle East respiratory syndrome coronavirus (MERS-CoV), US CDC, June 2015 http://www.cdc.gov/coronavirus/mers/infection-prevention-control.html [Accessed 27.05.16].
25. 25 Min, C.K., Cheon, S., Ha, N.Y., Sohn, K.M., Kim, Y., Aigerim, A., et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep, 6, 2016, 25359.
26. 26 Arabi, Y.M., Arifi, A.A., Balkhy, H.H., Najm, H., Aldawood, A.S., Ghabashi, A., et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 160 (2014), 389–397.
27. 27 Guery, B., Poissy, J., el Mansouf, L., Sejourne, C., Ettahar, N., Lemaire, X., et al. Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission. Lancet 381 (2013), 2265–2272.
28. 28 Choi, K.W., Chau, T.N., Tsang, O., Tso, E., Chiu, M.C., Tong, W.L., et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 139 (2003), 715–723.
29. 29 Lupovitch, A., White cell differential count and influenza A. Am J Med 118 (2005), 1306–1307 author reply 7–9.
30. 30 Yang, M., Ng, M.H., Li, C.K., Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology 10 (2005), 101–105.
31. 31 Le, V.B., Schneider, J.G., Boergeling, Y., Berri, F., Ducatez, M., Guerin, J.L., et al. Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. Am J Respir Crit Care Med 191 (2015), 804–819.
32. 32 Ying, T., Li, W., Dimitrov, D.S., Discovery of T cell infection and apoptosis by MERS Coronavirus. J Infect Dis 213 (2016), 877–879.
33. 33 Chu, H., Zhou, J., Wong, B.H., Li, C., Chan, J.F., Cheng, Z.S., et al. Middle East Respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates both the extrinsic and intrinsic apoptosis pathways. J Infect Dis 213 (2016), 904–914.
34. 34 Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., Al-Rabiah, F.A., Al-Hajjar, S., Al-Barrak, A., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13 (2013), 752–761.
35. 35 Chan, J.F., Lau, S.K., To, K.K., Cheng, V.C., Woo, P.C., Yuen, K.Y., Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 28 (2015), 465–522.